Dave & Buster's Entertainment Reports Disappointing Results, Alongside Adtran Holdings and Other Major Stocks Declining in Tuesday's Pre-Market Trading
U.S. Stock Futures: U.S. stock futures are up, with S&P 500 futures increasing by about 0.2% on Tuesday morning.
Dave & Buster's Performance: Dave & Buster’s shares fell 17.7% in pre-market trading after reporting second-quarter revenue of $557.41 million, which was below analyst expectations.
Other Stocks Declining: Several other stocks also saw declines in pre-market trading, including Monte Rosa Therapeutics (-10%), Adtran Holdings (-9.1%), and Oscar Health (-5%).
Market Reactions: The market is reacting to various company announcements, including convertible note offerings and collaborations, impacting stock prices negatively.
Trade with 70% Backtested Accuracy
Analyst Views on PLAY
About PLAY
About the author

- Investment Foundation: NNN REIT focuses on single-tenant properties, primarily investing in retail and service sectors with nearly 3,700 properties across 50 states, ensuring a stable income stream and low volatility, thereby enhancing investor confidence.
- High Dividend Yield: Currently, NNN REIT offers a dividend yield exceeding 5.5%, significantly higher than the REIT sector average of 4.4% and the S&P 500's 1.1%, making it a preferred choice for passive income investors and further enhancing its investment appeal.
- Financial Stability: NNN REIT holds a BBB+/Baa1 bond rating with a weighted average debt maturity of 10.7 years and $1.4 billion in liquidity, showcasing strong financial flexibility that supports future investments and dividend growth.
- Sustained Growth Potential: The company plans to invest $850 million to $950 million in the coming years, aiming to partially finance this through $170 million to $200 million in property sales, supporting mid-single-digit annual earnings per share growth and ensuring continued dividend increases.
- Market Performance: The S&P 500 index fell by 0.06%, the Dow Jones Industrial Average decreased by 0.17%, and the Nasdaq 100 dropped by 0.07%, reflecting market uncertainty regarding future interest rate policies.
- Rising Bond Yields: The 10-year Treasury yield rose by 6 basis points to 4.23%, reaching a 4.5-month high, as President Trump's reluctance to nominate Hassett intensified market concerns about potential rate hikes.
- Manufacturing Data: December manufacturing production unexpectedly increased by 0.2%, surpassing expectations of a 0.1% decline, indicating economic resilience that could influence the Fed's policy direction.
- Tech Stock Volatility: Chipmakers surged on renewed optimism for AI spending after TSMC raised its 2026 capital expenditure forecast, while power suppliers fell due to pressure from Trump's policy initiatives.
- Chip Stocks Rally: Chip manufacturers and data storage companies see stock prices rise due to optimism around AI spending, with Micron Technology (MU) leading gains in the S&P 500 and Nasdaq 100, up over 7% after TSMC raised its 2026 capital expenditure forecast.
- Manufacturing Strength: US manufacturing production unexpectedly rose by 0.2% in December, surpassing expectations of a 0.1% decline, while November's figure was revised up to 0.3%, indicating economic resilience that boosts market confidence.
- Positive Earnings Season: In the first full week of Q4 earnings season, 89% of the 28 S&P 500 companies that reported exceeded expectations, with Bloomberg Intelligence forecasting an 8.4% earnings growth for the S&P 500 in Q4, further enhancing market optimism.
- Interest Rate Impact: Despite the stock market's gains, the 10-year T-note yield has risen to 4.19%, limiting upside potential for stocks, with the market pricing only a 5% chance of a 25 bp rate cut at the upcoming FOMC meeting on January 27-28.
- Rating Upgrade: Deutsche Bank upgraded Coupang from hold to buy, citing the company's strong resilience against regulatory scrutiny, particularly after facing a record antitrust fine in June 2024, which has not diminished its market position.
- Biotech Outlook: Goldman Sachs upgraded BioNTech from neutral to buy, highlighting the company's strategic suite of oncology programs targeting a potential market exceeding $100 billion, with key data expected to unlock in 2026, positioning it for leadership in emerging product cycles.
- Market Challenges: Barclays downgraded HP from equal weight to underweight, noting that the company faces significant long-term challenges in both PCs and printing, which will likely keep the stock under pressure in 2026 despite its current inexpensive valuation and lack of catalysts.
- EV Market Positioning: Macquarie upgraded Nio from market perform to outperform, asserting that the company is well-positioned to navigate the current headwinds in the Chinese electric vehicle market, thereby maintaining its competitive edge.

Photronics Performance: Photronics saw a significant increase of over 37% in its stock price due to better-than-expected fiscal fourth-quarter results and optimistic first-quarter earnings guidance.
Maplebear Challenges: Maplebear's stock dropped 6% following Amazon's expansion of its same-day perishable grocery delivery service, which directly competes with Instacart.
United Natural Foods Outlook: United Natural Foods' shares fell more than 7% after it projected low single-digit average net sales growth through 2028.
Dave & Buster's and GE Vernova Gains: Dave & Buster's shares surged 15.5% despite missing earnings expectations, while GE Vernova's stock jumped 14% after positive revenue trends and a dividend increase.









